Concept Elicitation Qualitative Study: Migraine Patient Experiences with Zavegepant

First published 04/04/2025

Last updated 04/08/2026

EU PAS number:

EUPAS1000000442

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

C5301035_NIS protocol_Migraine Patient Experiences with Zavegepant_V1.0_20FEB2025_REDACTED.pdf

English (260.92 KB - PDF) View document

Study results

C5301035_NIS study report_V1.0_19Jun2026_Redacted.pdf

English (942.1 KB - PDF) View document

Study report

Abstract of study report

C5301035_Study Report Abstract_V1.0_19Jun2026_Redacted.pdf

English (78.28 KB - PDF) View document

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Concept Elicitation Qualitative Study: Migraine Patient Experiences with Zavegepant

Secondary tabs

Share this page